8 Nov 2022 , 07:58 AM
Net profit of Bliss GVS Pharma declined 34.88% to Rs 13.85 crore in the quarter ended September 2022 as against Rs 21.27 crore during the previous quarter ended September 2021. Sales declined 12.02% to Rs 172.43 crore in the quarter ended September 2022 as against Rs 195.99 crore during the previous quarter ended September 2021.
| Particulars | Quarter Ended | ||
| ? | Sep. 2022 | Sep. 2021 | % Var. |
| Sales | 172.43 | 195.99 | -12 |
| OPM % | 14.24 | 15.01 | – |
| PBDT | 24.79 | 34.18 | -27 |
| PBT | 20.19 | 29.89 | -32 |
| NP | 13.85 | 21.27 | -35 |
Powered by Capital Market – Live News
Related Tags
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
